📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease. (2021)

First Author: Jonasch E

Attributed to: Development of a 'humanised' model for renal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2103425

PubMed Identifier: 34818478

Publication URI: http://europepmc.org/abstract/MED/34818478

Type: Journal Article/Review

Volume: 385

Parent Publication: The New England journal of medicine

Issue: 22

ISSN: 0028-4793